There is no lab test that cleanly separates the two, and clinicians describe this as a genuinely difficult sorting problem.
One useful marker is timing: attention problems that trace back through childhood, even years of being compensated for, point toward ADHD that perimenopause has unmasked, while attention difficulties that are truly new for this stage of life lean toward a menopause-transition explanation. Perimenopause may also make genuine ADHD symptoms worse, and in a smaller group of women it may produce ADHD-like symptoms that are neither. One field heuristic is to watch whether symptoms ease as the hormonal transition stabilizes, since persistence over time is thought to argue more for unmasked ADHD. A full evaluation that looks across your whole life course, not just this year, is what actually distinguishes the possibilities.
Experts disagree about whether the sorting question even has a clean answer yet, because the strongest cohort finding of worse symptoms in women with ADHD sits alongside an equally rigorous null result, and no study has followed individual women's symptoms with childhood history and hormone staging together.
What the research shows, and which source each finding rests on
A systematic review of ADHD and female sex hormones (searches to January 2025) found only 11 studies in total, covering puberty, the menstrual cycle and pregnancy, and stated menopause still requires investigation.
In an Icelandic population cohort, women with self-reported ADHD (n=535) had a higher perimenopausal symptom burden than women without ADHD: Menopause Rating Scale 18.0 vs 13.0; severe symptoms 54.2% vs 30.1% (prevalence ratio 1.80).
A UK cross-sectional comparison of 656 women aged 45-60 (245 with ADHD) found no significant effect of an ADHD diagnosis on menopausal complaints after correction for multiple comparisons.
Where the real disagreement is
Each position is shown with its own sources. A position listed here is not necessarily the accepted view.
Timing and persistence as the sorting tool
menopause clinicians in the field-knowledge corpus
If attention and executive symptoms resolve as the hormonal transition stabilizes, that argues for a menopause-transition explanation; if they persist, that argues the woman was likely destined to be diagnosed with ADHD, or had lifelong ADHD that was highly compensated and has now been unmasked.
Careful reassessment reclassifies most apparent late-onset cases
researchers studying late-onset ADHD longitudinally
In the strongest longitudinal study of apparent late-onset ADHD, about 95 percent of people who initially screened positive were excluded on careful assessment, usually because symptoms were better explained by substance use, mood disorders, or normal cognitive fluctuation - a caution against assuming new midlife attention complaints equal new ADHD.
What would settle it: Longitudinal cohorts that track measured ADHD symptoms through the transition with childhood-history ascertainment and hormonal staging, plus treatment trials comparing stimulants, hormone therapy, and their combination in women with and without validated childhood-onset ADHD.
What is really going on here
- Does hormone therapy improve ADHD symptoms in perimenopausal women who have ADHD - never trialed.
- What fraction of new midlife ADHD diagnoses would survive a structured assessment that checks for childhood onset - unknown.
- Is hormone volatility or the absolute estrogen level the operative variable in attention symptoms - untested.
Questions for your doctor
- Can we go through my attention and focus history all the way back to childhood, not just this past year?
- Could my symptoms be explained by the menopause transition itself before we consider an ADHD diagnosis?
- If we're not sure yet, can we revisit this in a few months to see if things have changed?
- Are there other explanations, like thyroid function, worth ruling out first?
Questions with no answer yet
Would tracking a woman's ADHD symptoms objectively, with confirmed childhood history, actually show they get worse through the transition, or does perceived worsening mostly reflect how hard midlife is in general?
Partly studiedWhat is known: One population cohort found women with self-reported ADHD had markedly higher perimenopausal symptom burden than women without ADHD, while a separate, corrected cross-sectional study of 656 women found no significant effect of an ADHD diagnosis on menopausal complaints. No longitudinal study has tracked measured ADHD symptoms through the transition with hormonal staging.
What would test it: A longitudinal cohort tracking measured ADHD symptoms through the transition with childhood-history ascertainment and hormonal staging.
Does hormone volatility, rather than the absolute level of estrogen, drive attention symptoms during the transition?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: This volatility-versus-absolute-level distinction is described as a genuine hypothesis in this area that no study has tested against measured ADHD symptoms.
What would test it: Repeated hormonal sampling paired with objective attention measures across the transition, comparing women with stable versus fluctuating estradiol.
Would combining stimulant treatment with hormone therapy help attention symptoms more than either alone?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: No randomized trial of any ADHD treatment, alone or combined with hormone therapy, has been conducted specifically in perimenopausal or postmenopausal women; current practice relies on expert consensus and extrapolation from younger cohorts, and this specific combination trial has been named as a top research priority.
What would test it: A randomized trial comparing stimulant, hormone therapy, and their combination in perimenopausal women with validated childhood-onset ADHD.
Sources
- 1.ADHD and Sex Hormones in Females: A Systematic Review.Osianlis E et al., J Atten Disord 2025;29(9):706-723 · Systematic review or guideline
- 2.Perimenopausal symptoms in women with and without ADHD: A population-based cohort study.Jakobsdottir Smari U et al., Eur Psychiatry 2025;68(1):e133 · Observational study
- 3.Examining the Link Between ADHD Symptoms and Menopausal Experiences.Chapman L et al., J Atten Disord 2025;29(14):1263-1277 · Observational study
- 4.Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause.Wynchank D, Kooij S, Drugs Aging 2026;43(5):385-395 · Systematic review or guideline
- 5.Dr. Lisa Mosconi, field interview (video)Review, opinion or mechanism
- 6.Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.Sibley MH et al., Am J Psychiatry 2018;175(2):140-149 · Observational study
The letter grades the type of study behind a claim, not the answer itself.
This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.
You are not imagining it
In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.
Start Free MappingRelated questions
- Why are so many women getting diagnosed with ADHD in their 40s all of a sudden?
- The stimulant medication helped me focus - doesn't that prove I have ADHD?
- Can perimenopause make an autoimmune condition flare up or get worse?
- Can I take hormone therapy if I have lupus?
- Does hormone therapy help or hurt rheumatoid arthritis around menopause?
- Does menopause make multiple sclerosis worse?
- Back to topic: ADHD, autoimmune conditions and histamine